Lack of cell cycle regulation of telomerase activity in human cells.

Conflicting reports have appeared concerning the cell cycle regulation of telomerase activity and its possible repression during quiescence and cell differentiation. We have reexamined these issues in an attempt to uncover the basis for the discrepancies. Variations in extracted telomerase activity during the cell cycle are not observed in cells sorted on the basis of DNA content. Variations are observed in cells synchronized using some biochemical cell cycle inhibitors, but only with those agents where cellular toxicity is evident. A progressive decline in telomerase activity is observed in cells whose growth rate is reduced from seven to eight population doublings per week to one to two doublings per week. Telomerase is largely absent in cells that truly exit the cell cycle and do not divide over the 7-day period. Although it is not necessary for all cell types to regulate telomerase in the same way, we conclude that in the immortal cultured cell lines examined, extracted telomerase activity does not change significantly during progression through the stages of the cell cycle. Telomerase activity generally correlates with growth rate and is repressed in cells that exit the cell cycle and become quiescent.

[1]  J. Shay,et al.  Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  D. Shibata,et al.  Telomerase activity in normal and neoplastic breast. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  H. W. Sharma,et al.  Telomerase activity in normal human endothelial cells. , 1997, Anticancer research.

[4]  S. Kyo,et al.  Telomerase activity in human endometrium. , 1997, Cancer research.

[5]  J. Shay,et al.  Telomerase activity concentrates in the mitotically active segments of human hair follicles. , 1997, The Journal of investigative dermatology.

[6]  J. Shay,et al.  Comparison of the telomeric repeat amplification protocol (TRAP) to the new TRAP-eze telomerase detection kit , 1996 .

[7]  J. Shay,et al.  Telomerase activity in human intestine. , 1996, International journal of oncology.

[8]  K. Riabowol,et al.  Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines. , 1996, Cancer research.

[9]  M. Mandal,et al.  Cell cycle-dependent modulation of telomerase activity in tumor cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Shay,et al.  Regulation of telomerase activity in immortal cell lines , 1996, Molecular and cellular biology.

[11]  E. Dmitrovsky,et al.  Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines. , 1996, Cancer research.

[12]  J. McDougall,et al.  Telomerase activation by the E6 gene product of human papillomavirus type 16 , 1996, Nature.

[13]  L. Gollahon,et al.  Immortalization of human mammary epithelial cells transfected with mutant p53 (273his). , 1996, Oncogene.

[14]  J. Shay,et al.  Telomerase activity in human cancer. , 1996, Current opinion in oncology.

[15]  J. Shay,et al.  Telomerase activity in human germline and embryonic tissues and cells. , 1996, Developmental genetics.

[16]  A. Sartorelli,et al.  Differentiation of immortal cells inhibits telomerase activity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Shay,et al.  Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. , 1995, Journal of immunology.

[18]  M. Oshimura,et al.  Restoration of the Cellular Senescence Program and Repression of Telomerase by Human Chromosome 3 , 1995, Japanese journal of cancer research : Gann.

[19]  D. Broccoli,et al.  Telomerase activity in normal and malignant hematopoietic cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Reddel,et al.  Telomere elongation in immortal human cells without detectable telomerase activity. , 1995, The EMBO journal.

[21]  B. Leber,et al.  Telomerase activity in normal leukocytes and in hematologic malignancies. , 1995, Blood.

[22]  J. Shay,et al.  Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP) , 1995 .

[23]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[24]  C. Greider,et al.  Telomerase activity in germline and embryonic cells of Xenopus. , 1994, The EMBO journal.

[25]  T. Kwok,et al.  Up-regulation of a mutant form of p53 by doxorubicin in human squamous carcinoma cells. , 1994, Cancer research.

[26]  J. Shay,et al.  E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts. , 1993, Oncogene.

[27]  C B Harley,et al.  Telomere length predicts replicative capacity of human fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[28]  C B Harley,et al.  Telomere end-replication problem and cell aging. , 1992, Journal of molecular biology.

[29]  J. Steitz,et al.  Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. , 1992, The EMBO journal.

[30]  J. Shay,et al.  A role for both RB and p53 in the regulation of human cellular senescence. , 1991, Experimental cell research.

[31]  C B Harley,et al.  Telomere loss: mitotic clock or genetic time bomb? , 1991, Mutation research.

[32]  C. Greider Telomeres, telomerase and senescence , 1990, BioEssays : news and reviews in molecular, cellular and developmental biology.

[33]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[34]  R. Myers,et al.  Structure and variability of human chromosome ends , 1990, Molecular and cellular biology.

[35]  J. Shay,et al.  Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts , 1989, Molecular and cellular biology.

[36]  A M Olovnikov,et al.  A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. , 1973, Journal of theoretical biology.

[37]  J. Yudkin Sugar and Disease , 1972, Nature.

[38]  L. Hayflick THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.